Type 1 diabetes: a combination therapy improves glucose control and performance of artificial pancreases
A publication in Nature Medicine by RI-MUHC researchers describes...
Fall 2021 CIHR competition results
RI-MUHC teams received $9.5 million in project funding
Three renewed Canada Research Chairs for RI-MUHC researchers
Ahmad Haidar, Dennis Jensen and Ian Watson are part of the McGill University cohort of 17 new and renewed Canada Research Chairs
RI-MUHC researchers are successful co-leaders in “100 years of insulin” funding call
Pan-Canadian team receives financing to develop a national pediatric diabetes registry
RI-MUHC team studies a novel, fully automated insulin delivery system
A new publication in Lancet Digital Health describes an important step that may improve glucose control and quality of life for people with type 1...
The 2021 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
Discovery of mechanics of drug targets for COVID-19
Scientists unravel inner workings of cell receptors involved in inflammatory diseases
RI-MUHC scientist part of McGill team delivering World Alzheimer Report 2021
Alzheimer’s Disease International webinar launches report on World Alzheimer Day, September 21
In Memoriam: Hugh Bennett, PhD
Remembering a superb peptide chemist, exceptional collaborator and defender of student welfare
New G protein inhibitor identified, with potential for cancer therapies
RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells